Sionna Therapeutics Director Sells $5.27M in Stock Amid Mixed Analyst Outlook
Peter A. Thompson, a director at Sionna Therapeutics, Inc. (NASDAQ: SION), executed a sale of common stock valued at approximately $5.27 million, according to a report filed on June 30, 2026. The transaction involved the disposal of 115,844 shares at $45.50 per share. While SION shares currently trade at $43.99, the sale comes against a backdrop of…